15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 21 firms covering Doximity Inc, 8 rate it Buy or better, 12 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $18.00 to $44.00 (about 2.4x), a sign of real disagreement on valuation. The average target of $26.37 sits 23% above the current $21.42. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.37 next quarter toward $1.59 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS21 ratings
Moderate Buy
Strong Buy15%
Buy733%
Hold1257%
Sell15%
Strong Sell00%
Based on 21 analysts giving stock ratings to Doximity Inc.
As of Jul, 8 of 21 firms rate DOCS a Buy (12 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
DOCS EPS & revenue forecast
EPS · NEXT QUARTER
$0.37
Range $0.32 – $0.42 · 18 analysts · -17% YoY
Next period, 18 analysts expect Doximity Inc to earn $0.37 a share (range $0.32 – $0.42), versus $0.45 a year earlier. Full-year consensus is $1.43, growing to $1.59 the year after.
REVENUE · NEXT QUARTER
$171.8M
Range $164.0M – $183.4M · 18 analysts · +2% YoY
Revenue is expected to reach $171.8M (range $164.0M – $183.4M), +1.9% year-over-year. Full-year consensus is $670.3M, rising to $712.4M next year.
Top analysts covering Doximity Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DOCS.
#1
Brian Peterson
Raymond James · Rank #335
Buy
No targeton DOCS
Overall win rate
27%
+ Follow
#2
Scott Schoenhaus
Keybanc · Rank #345
Hold
No targeton DOCS
Overall win rate
29%
+ Follow
#3
Ryan MacDonald
Needham · Rank #386
Buy
$27.00+26.1% to target
Overall win rate
17%
+ Follow
#4
Stan Berenshteyn
Wells Fargo
Hold
$18.00-16.0% to target
Coverage
—
+ Follow
#5
David Roman
Goldman Sachs
Hold
$24.00+12.0% to target
Coverage
—
+ Follow
DOCS stock forecast FAQ
What is DOCS's average 12-month price target?+
The 19 analysts with a live target average $26.37 for Doximity Inc over the next 12 months, ranging from a $44.00 high to a $18.00 low.
Is DOCS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 21 analyst ratings, 8 are Buy or Strong Buy, 12 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for DOCS?+
The Street-high target is $44.00 (RBC Capital), and the Street-low is $18.00 (Wells Fargo). The average of all 19 active targets is $26.37.
How many Wall Street analysts cover DOCS?+
21 analysts have an active rating on Doximity Inc, and 19 firms carry a live 12-month price target.
Who is the most accurate analyst covering DOCS?+
Among analysts who currently cover DOCS, Brian Peterson of Raymond James has the strongest overall Quantellect track record (Rank #335). Their current call is Buy.
What is Doximity Inc's projected EPS for next quarter?+
The consensus estimate is $0.37 per share (range $0.32 – $0.42) across 18 analysts. Full-year EPS is projected at $1.43, rising to $1.59 the following year.
How much revenue is Doximity Inc expected to report next quarter?+
Consensus revenue is $171.8M (range $164.0M – $183.4M). Full-year revenue is projected at $670.3M, growing to $712.4M next year.
Have analysts been upgrading or downgrading DOCS lately?+
As of Jul, 8 of 21 firms rate DOCS a Buy (12 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DOCS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
